Systematic review and meta-analysis of the efficacy and safety of SGLT2 inhibitors in patients with type 2 diabetes mellitus

Схожие документы

• Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.
  по: Karagiannis, T, и др.
  Опубликовано: (2012)
• Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.
  по: Vasilakou, D, и др.
  Опубликовано: (2013)
• In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes
  по: Ng, SYA, и др.
  Опубликовано: (2020)
• Efficacy and safety of canagliflozin (CANA), an inhibitor of sodium glucose co-transporter 2 (SGLT2), added-on to insulin therapy plus /- oral agents in type 2 diabetes
  по: Matthews, DR, и др.
  Опубликовано: (2012)
• Safety of metformin in Type 2 diabetes mellitus.
  по: Baigent, C, и др.
  Опубликовано: (1999)